StockWatch
·
Pharmaceuticals
Shareholding16 Jun 2026, 06:10 pm

Trident Lifeline Subsidiary Private Placement Reduces Parent Stake

AI Summary

Trident Lifeline Ltd announced that its subsidiary, Trident Mediquip Limited (TML), has completed a private placement of equity shares. Following this placement to other shareholders, Trident Lifeline's shareholding in TML has decreased from 58.84% to 58.67%. TML operates in the Medical Device Industry and had a turnover of ₹27.31 Cr in FY26. The transaction is considered a related party transaction as TML is a subsidiary, but it is being conducted on an arm's length basis. No specific financial consideration or acquisition details were provided as the transaction involved existing shareholders.

Key Highlights

  • Subsidiary Trident Mediquip completed private placement of equity shares.
  • Trident Lifeline's stake in subsidiary reduced to 58.67%.
  • TML operates in the Medical Device Industry with FY26 turnover of ₹27.31 Cr.
  • Transaction is on an arm's length basis despite being a related party.